Gluglic® Mr 60 mg

Active ingredient: Gliclazide 60 mg
Therapeutic category: Antidiabetic
Indications: Adequate glycemic control in 65% of patients after 3 months of treatment.
*For more information download the medical insert.
Presentation: Box of 30 modified-release tablets.
Dosage: Consult your physician.